Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution.
第一作者:
Sonali,Lakshminarayanan
第一单位:
Division of Pediatric Hematology/Oncology and Stem Cell Transplantation, Schneider Children's Hospital, North Shore-Long Island Jewish Health System, New Hyde Park, NY 11040, USA.
作者:
医学主题词
青少年(Adolescent);抗凝药(Anticoagulants);化学预防(Chemoprevention);儿童(Child);儿童, 学龄前(Child, Preschool);女(雌)性(Female);谷氨酰胺(Glutamine);造血干细胞移植(Hematopoietic Stem Cell Transplantation);肝素(Heparin);肝静脉闭塞性疾病(Hepatic Veno-Occlusive Disease);人类(Humans);发病率(Incidence);婴儿(Infant);男(雄)性(Male);熊脱氧胆酸(Ursodeoxycholic Acid);青年人(Young Adult)
DOI
10.1111/j.1399-3046.2009.01285.x
PMID
20051023
发布时间
2013-11-21
- 浏览14
Pediatric transplantation
618-21页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



